Related Experiment Video

Updated: Jun 14, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular

Qian Xu1, Shannamar Dewey, Susan Nguyen

  • 1Department of Neurobiology, Physiology and Behavior, University of California, Davis, One Shields Avenue, CA 95616, USA.

Journal of Molecular and Cellular Cardiology
|March 20, 2010
PubMed

Insights

Genetic factors significantly influence cardiomyopathies, including hypertrophic (HCM), dilated (DCM), restrictive (RCM), and ventricular noncompaction (VNCM). Understanding these genetic determinants is crucial for predicting disease severity and patient prognosis.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are a leading cause of cardiac death and heart transplantation.
  • Hypertrophic cardiomyopathy (HCM) affects 0.2% of the population and is a primary cause of sudden death in young adults.
  • Dilated cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), and ventricular noncompaction cardiomyopathy (VNCM) are also associated with severe cardiac events.

Purpose of the Study:

  • To review the complex cardiovascular phenotypes and genetic variability in HCM, DCM, RCM, and VNCM.
  • To explore the role of genetic determinants in disease pathogenesis and phenotypic variability.
  • To discuss the impact of genetic modifiers and protein-protein interactions on cardiomyopathy severity.

Main Methods:

  • Review of current literature on genetic mutations and cardiomyopathies.
  • Analysis of identified mutations in sarcomeric genes associated with HCM, DCM, RCM, and VNCM.
  • Discussion of genotype-phenotype correlations and contributing factors to disease severity.

Main Results:

  • Over 630 mutations in 10 sarcomeric genes are linked to cardiomyopathies.
  • HCM is associated with over 550 mutations, DCM with 52, RCM with 14, and VNCM with 17.
  • Homozygosity or compound heterozygosity for mutations, genetic modifiers, and altered protein interactions contribute to more severe phenotypes and poorer prognoses.

Conclusions:

  • Genetic variability plays a critical role in the pathogenesis and phenotypic spectrum of cardiomyopathies.
  • Understanding genetic determinants and modifiers is essential for predicting disease progression and outcomes.
  • Further research into protein-level changes may elucidate mechanisms underlying different cardiomyopathy types.

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...